127 related articles for article (PubMed ID: 2930998)
1. Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Clinical aspects.
Nyström C; Hällström T
Acta Psychiatr Scand; 1985 Jul; 72(1):6-15. PubMed ID: 2930998
[TBL] [Abstract][Full Text] [Related]
2. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Biochemical aspects.
Nyström C; Ross SB; Hällström T; Kelder D
Acta Psychiatr Scand; 1986 Feb; 73(2):133-8. PubMed ID: 2939691
[TBL] [Abstract][Full Text] [Related]
3. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study.
Nyström C; Hällström T
Acta Psychiatr Scand; 1987 Apr; 75(4):377-82. PubMed ID: 3035878
[TBL] [Abstract][Full Text] [Related]
4. Zimelidine vs maprotiline in depressed outpatients. A preliminary report.
d'Elia G; Hällström T; Nyström C; Ottosson JO
Acta Psychiatr Scand Suppl; 1981; 290():225-35. PubMed ID: 6452793
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
Timmerman L; de Beurs P; Tan BK; Leijnse-Ybema H; Sanchez C; Høpfner Petersen HE; Cohen Stuart MH
Int Clin Psychopharmacol; 1987 Jul; 2(3):239-53. PubMed ID: 2447151
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials with new bicyclic and tetracyclic compounds: zimelidine and maprotiline [proceedings].
Claghorn JL; Mathew RJ
Psychopharmacol Bull; 1981 Jan; 17(1):23-6. PubMed ID: 6453355
[No Abstract] [Full Text] [Related]
7. Zimeldine versus nomifensine. A double-blind study of depressed inpatients.
Knudsen P; Bjørndal N; Johnsen T; Pfeiffer Petersen K
Neuropsychobiology; 1984; 11(4):236-42. PubMed ID: 6238240
[TBL] [Abstract][Full Text] [Related]
8. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.
Eberhard G; von Knorring L; Nilsson HL; Sundequist U; Björling G; Linder H; Svärd KO; Tysk L
Neuropsychobiology; 1988; 19(1):25-34. PubMed ID: 3054623
[TBL] [Abstract][Full Text] [Related]
9. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
Poelinger W; Haber H
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
[No Abstract] [Full Text] [Related]
11. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline.
Den Boer JA; Westenberg HG
Int Clin Psychopharmacol; 1988 Jan; 3(1):59-74. PubMed ID: 2833543
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
[No Abstract] [Full Text] [Related]
13. A multicentre double-blind comparative trial of zimeldine and imipramine in primary major depressive disorders.
Hiramatsu KI; Takahashi R; Mori A; Inoue R; Kazamatsuri H; Murasaki M; Sakuma A
Acta Psychiatr Scand Suppl; 1983; 308():41-54. PubMed ID: 6230895
[TBL] [Abstract][Full Text] [Related]
14. Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.
Bouchard JM; Delaunay J; Delisle JP; Grasset N; Mermberg PF; Molczadzki M; Pagot R; Richou H; Robert G; Ropert R
Acta Psychiatr Scand; 1987 Nov; 76(5):583-92. PubMed ID: 3324648
[TBL] [Abstract][Full Text] [Related]
15. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
Fabre LF
J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G
Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
Faltus F; Filip V; Karen P; Kolomazník M; Korínková V; Libiger J; Molcan J; Zapletálek M; Zizka V
Cesk Psychiatr; 1986 Apr; 82(2):131-8. PubMed ID: 3524870
[No Abstract] [Full Text] [Related]
18. A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
Palha AP; Ferreira L; Abreu-Lima C; Ramalhão C; Fernandes R
Clin Ther; 1985; 7(5):584-92. PubMed ID: 3902238
[TBL] [Abstract][Full Text] [Related]
19. Relationship between blood concentrations and clinical effects of a new antidepressant "maprotiline".
Watanabe S; Yokoyama S; Kubo S; Iwai H; Kuyama C
Folia Psychiatr Neurol Jpn; 1980; 34(2):147-56. PubMed ID: 7007180
[TBL] [Abstract][Full Text] [Related]
20. Worldwide clinical experience with ludiomil.
Dillier
Act Nerv Super (Praha); 1982 May; 24(2):40-54. PubMed ID: 7048834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
